Business Wire
11 Jun 2026, 20:39 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
The USPTO has issued a Notice of Allowance for Xeris Pharmaceuticals' U.S. Patent Application No. 17/151,405 regarding compositions and methods of use. — Patent allowances protect intellectual property and extend market exclusivity, which typically increases the valuation of biopharmaceutical companies.
+0.60Which stocks this story touches
The company received a Notice of Allowance from the USPTO for a patent application, strengthening its intellectual property portfolio.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
10h ago
